Articles related to CHILD & ADOLESCENT PSYCHIATRY

Mean adjusted adult BMI was significantly higher among individuals with childhood ADHD compared with controls, with the highest BMI observed in those treated with MPH for ≥365 days.

Although not remarkably high, a 2.8% development of psychotic symptoms represents a nonnegligible figure and lends further meta-analytic support to the 2007 FDA change in the drug label for stimulants.

Progress in perinatal care has improved survival for children born very preterm (VPT), but these children remain at higher risk of cognitive impairment compared with children born at term.

“These autism sensory differences—from altered habituation patterns in utero to atypical newborn responses—offer clinicians measurable indicators that precede behavioral presentations.”

Triple-release dexmethylphenidate formulation demonstrated dose-dependent ADHD symptom improvements with effect sizes ranging from 0.737 to 1.185 across all tested doses in pediatric patients.

Clinical practice observations of AVN following hip injury where non-adherence to activity restrictions was a contributing factor highlight the intersection of medication effects and behavioral challenges in ADHD patients.